Felipe Sandoval

412 total citations
19 papers, 340 citations indexed

About

Felipe Sandoval is a scholar working on Hematology, Infectious Diseases and Oncology. According to data from OpenAlex, Felipe Sandoval has authored 19 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Infectious Diseases and 6 papers in Oncology. Recurrent topics in Felipe Sandoval's work include Multiple Myeloma Research and Treatments (13 papers), Leprosy Research and Treatment (11 papers) and Infectious Diseases and Tuberculosis (4 papers). Felipe Sandoval is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Leprosy Research and Treatment (11 papers) and Infectious Diseases and Tuberculosis (4 papers). Felipe Sandoval collaborates with scholars based in United States, Brazil and Qatar. Felipe Sandoval's co-authors include Emer Shannon, Robert J. Noveck, James L. Krahenbuhl, Burde L. Kamath, Diana L. Williams, Michael T. Kearney, Milton Ozório Moraes, Euzenir Nunes Sarno, María Cristina Vidal Pessolani and Patrícia Sammarco Rosa and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Felipe Sandoval

19 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felipe Sandoval United States 11 155 130 96 89 67 19 340
Anne Nihtinen Finland 12 152 1.0× 93 0.7× 109 1.1× 54 0.6× 102 1.5× 24 377
Koki Ueda Japan 13 194 1.3× 120 0.9× 122 1.3× 210 2.4× 74 1.1× 34 563
Gérard Pivert France 7 189 1.2× 99 0.8× 75 0.8× 79 0.9× 44 0.7× 7 469
Gabriela Rodríguez‐Macías Spain 11 166 1.1× 90 0.7× 41 0.4× 94 1.1× 73 1.1× 30 361
Effie Liakopoulou United Kingdom 10 204 1.3× 133 1.0× 110 1.1× 102 1.1× 176 2.6× 21 518
Donata Urbaniak‐Kujda Poland 12 91 0.6× 81 0.6× 37 0.4× 98 1.1× 130 1.9× 37 416
A. Insunza Spain 9 163 1.1× 46 0.4× 60 0.6× 82 0.9× 80 1.2× 24 366
Masumi Fujishima Japan 12 76 0.5× 61 0.5× 48 0.5× 50 0.6× 69 1.0× 26 361
Fumihiko Monma Japan 13 317 2.0× 70 0.5× 93 1.0× 112 1.3× 89 1.3× 35 496
Federica Lessi Italy 8 139 0.9× 33 0.3× 65 0.7× 89 1.0× 137 2.0× 30 377

Countries citing papers authored by Felipe Sandoval

Since Specialization
Citations

This map shows the geographic impact of Felipe Sandoval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Sandoval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Sandoval more than expected).

Fields of papers citing papers by Felipe Sandoval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felipe Sandoval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Sandoval. The network helps show where Felipe Sandoval may publish in the future.

Co-authorship network of co-authors of Felipe Sandoval

This figure shows the co-authorship network connecting the top 25 collaborators of Felipe Sandoval. A scholar is included among the top collaborators of Felipe Sandoval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felipe Sandoval. Felipe Sandoval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ribeiro‐Alves, Marcelo, Luciana Silva Rodrigues, Bruno Jorge de Andrade Silva, et al.. (2016). STING-Dependent 2′-5′ Oligoadenylate Synthetase–Like Production Is Required for IntracellularMycobacterium lepraeSurvival. The Journal of Infectious Diseases. 214(2). 311–320. 33 indexed citations
2.
Ribeiro‐Alves, Marcelo, Patrícia Sammarco Rosa, Felipe Sandoval, et al.. (2013). Gene Expression Profiling Specifies Chemokine, Mitochondrial and Lipid Metabolism Signatures in Leprosy. PLoS ONE. 8(6). e64748–e64748. 39 indexed citations
3.
Williams, Diana L., et al.. (2013). Drug Resistance in Patients With Leprosy in the United States. Clinical Infectious Diseases. 58(1). 72–73. 18 indexed citations
4.
5.
Sandoval, Felipe, et al.. (2011). Thalidomide delayed the ability of 4T1 cells to amass into tumors in Balb/c mice. Immunopharmacology and Immunotoxicology. 34(3). 408–412. 1 indexed citations
6.
Sandoval, Felipe, et al.. (2011). In vitro thalidomide does not interfere with the activation of complement by M. leprae.. PubMed. 10(3). 274–8. 2 indexed citations
7.
8.
Noveck, Robert J., et al.. (2008). Thalidomide Suppressed IL-1β While Enhancing TNF-α and IL-10, When Cells in Whole Blood were Stimulated with Lipopolysaccharide. Immunopharmacology and Immunotoxicology. 30(3). 447–457. 21 indexed citations
9.
Shannon, Emer & Felipe Sandoval. (2008). Thalidomide and Thalidomide Transformed by pH-Dependent Hydrolysis or by Liver Enzyme Treatment Does Not Impede the Proliferation of Endothelial Cells. Immunopharmacology and Immunotoxicology. 30(2). 307–316. 2 indexed citations
10.
Lahiri, Ramanuj, et al.. (2008). Activation of complement by Mycobacterium leprae requires disruption of the bacilli. Leprosy Review. 79(3). 311–314. 6 indexed citations
11.
Noveck, Robert J., et al.. (2007). Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia. Translational research. 150(5). 275–280. 27 indexed citations
12.
Sandoval, Felipe, et al.. (2004). Stabilization of Red Blood Cell Membranes by Thalidomide In Vitro. Immunopharmacology and Immunotoxicology. 26(4). 501–509. 7 indexed citations
13.
14.
Sandoval, Felipe, et al.. (2002). Thalidomide can costimulate or suppress CD4+ cells' ability to incorporate [H3]-thymidine—dependence on the primary stimulant. International Immunopharmacology. 2(8). 1143–1153. 10 indexed citations
15.
Shannon, Emer, Abraham Aseffa, George A. Pankey, Felipe Sandoval, & Brianna Marie Lutz. (2000). Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood. Immunopharmacology. 46(2). 175–179. 17 indexed citations
16.
Sandoval, Felipe, et al.. (1997). Immunomodulatory assays to study structure-activity relationships of thalidomide. Immunopharmacology. 35(3). 203–212. 21 indexed citations
17.
Shannon, Emer, Felipe Sandoval, & James L. Krahenbuhl. (1997). Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-α. Immunopharmacology. 36(1). 9–15. 27 indexed citations
18.
Sandoval, Felipe, et al.. (1996). Thalidomide Can Be Either Agonistic or Antagonistic to LPS Evoked Synthesis of Tnf-α by Mononuclear Cells. Immunopharmacology and Immunotoxicology. 18(1). 59–72. 37 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Nihtinen Breakdown of academic impact, for papers by Koki Ueda Breakdown of academic impact, for papers by Gérard Pivert Breakdown of academic impact, for papers by Gabriela Rodríguez‐Macías Breakdown of academic impact, for papers by Effie Liakopoulou Breakdown of academic impact, for papers by Donata Urbaniak‐Kujda Breakdown of academic impact, for papers by A. Insunza Breakdown of academic impact, for papers by Masumi Fujishima Breakdown of academic impact, for papers by Fumihiko Monma Breakdown of academic impact, for papers by Federica Lessi
Rankless by CCL
2026